Financials data is unavailable for this security.
View more
Year on year DR Horton Inc had little change in net income (from 4.75bn to 4.76bn) despite revenues that grew 3.78% from 35.46bn to 36.80bn. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 9.15% to 9.77%.
Gross margin | 26.06% |
---|---|
Net profit margin | 13.06% |
Operating margin | 17.08% |
Return on assets | 13.99% |
---|---|
Return on equity | 19.82% |
Return on investment | 17.33% |
More ▼
Cash flow in USDView more
In 2024, DR Horton Inc increased its cash reserves by 16.51%, or 643.90m. The company earned 2.19bn from its operations for a Cash Flow Margin of 5.95%. In addition the company used 190.60m on investing activities and also paid 1.36bn in financing cash flows.
Cash flow per share | 14.75 |
---|---|
Price/Cash flow per share | 10.72 |
Book value per share | 78.12 |
---|---|
Tangible book value per share | 77.61 |
More ▼
Balance sheet in USDView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.2338 |
---|---|
Total debt/total capital | 0.1864 |
More ▼
Growth rates in USD
SmartText is unavailable
Div yield(5 year avg) | 0.88% |
---|---|
Div growth rate (5 year) | 14.87% |
Payout ratio (TTM) | 8.31% |
EPS growth(5 years) | 27.31 |
---|---|
EPS (TTM) vs TTM 1 year ago | 3.69 |
More ▼